Emily Kaiser Maharjan, Assistant Managing Editor

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation, which covered 12 new treatments all optometrists should know about.

Justin Schweitzer, OD, FAAO, and Nathan Lighthizer, OD, provide key takeaways from their 2023 AOA presentation, "Beyond drops: Surgical considerations in glaucoma," which they will give alongside Walter Whitley, OD, MBA, FAAO.

Kevin Chan, OD, MS, FAAO, gives us an insider look at his AOA 2023 presentation, "Top 5 myths of myopia management and how to overcome them."

Charissa Lee discusses diversity, equity, and inclusion within her role at Johnson & Johnson Vision and in the industry overall.

Graham Erickson, OD, FAAO, FCOVD, gives key takeaways of his presentation, "Sports vision grand rounds," which he presented during the 2023 AOA Optometry's Meeting in Washington, DC.

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation that discussed the pharmaceutical treatment of anterior segment inflammatory conditions.

Jessilin Quint, OD, MBA, MS, FAAO, shares the latest and greatest in the world of dry eye, from new technology to how clinicians can start in on dry eye therapy today.

Jeffry Gerson, OD, FAAO, who presented a poster on the Light Site 3 clinical study at the AOA online e-poster event, discusses a promising new treatment for patients with AMD.

Howard Purcell, OD, FAAO, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).

Bill Reindel, OD, gives an overview of his e-poster, "Practitioner assessment of fitting a novel silicone hydrogel daily disposable multifocal contact lens," which he presented at AOA 2023.

Annual meeting places spotlight on newest clinical techniques, industry trends.

Karen Carrasquillo, OD, PhD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).

The water-free, preservative-free, anti-inflammatory drop from Novaliq, now coined Vevye, received FDA approval to treat the signs and symptoms of dry eye disease.

Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses leverage Bausch + Lomb’s proprietary lens tech to deliver all-day comfort and seamless transitions between near, intermediate, and distance vision for patients with presbyopia.

Since April 2022, the Dry Eye Foundation has been voicing concerns over the packaging of preservative-free drops as well as availability of noncompliant drops at online retailers.

Diagnose, monitor, comanage—optometrists support patients throughout all stages of the disease.

MIEBO, previously known as NOV03, is the first and only FDA-approved treatment for dry eye disease that targets tear evaporation.

Today, Alimera Sciences announced that they have acquired the US commercial rights of Yutiq (fluocinolone acetonide intravitreal insert) 0.18mg for the treatment of chronic non-infectious uveitis. Yutiq now joins Iluvien (fluocinolone acetonide intravitreal insert) 0.19 mg for DME in Alimera’s retina portfolio.

The DR:EAM study in investigating novel eye drop OTT-166 for the treatment of diabetic retinopathy in hopes of reducing treatment burden for patients.

Xiongfei Liu, MD, is presenting a talk entitled, "Effectiveness and safety of combining 2 MIGS devices in patients with open angle glaucoma," at ASCRS 2023 in San Diego, California.

The medical technology company ViaLase will reveal the 2-year data from their FLigHT clinical study as well as give additional information about their pipeline at ASCRS 2023.

Robert Maloney, MD, shares a sneak peek of his presentation and what he's looking forward to during the symposium.

Jill Saxon, OD, returns to Optometry Times On Air to discuss industry achievements, including the launch of the Women's Leadership Network and the Military Network at Bausch + Lomb.

The aspheric, monofocal, single-piece C-loop IOL from Zeiss compensates for a range of spherical aberrations to minimize decentration and lens misalignments.

Jamie Kuzniar, OD, discusses scleral lens fitting for patients with keratoconus at the IKA Keratoconus Symposium in Scottsdale, Arizona.

Positive 42-month Cypress axial length and cSER outcomes, presented at ARVO in New Orleans, reinforce myopia control safety and efficacy of Diffusion Optics Technology™ spectacle lenses.

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.

Today at the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.

President and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.

Co-founder of the International Keratoconus Academy S. Barry Eiden, OD, FAAO, FSLS, gives us the inside scoop on the inaugural IKA Keratoconus Symposium, which takes place this weekend in Scottsdale, Arizona.